These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8266540)

  • 21. Relationship between donor factors, immunogenic up-regulation, and outcome after kidney transplantation.
    Nyhof E; Wiehl S; Steinhoff J; Krüger S; Mueller-Steinhardt M; Fricke L
    Transplant Proc; 2005 Apr; 37(3):1605-7. PubMed ID: 15866685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary analysis of HLA matching in pancreas and liver transplantation. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1993 Aug; 25(4):2652-3. PubMed ID: 8356708
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
    Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
    Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
    Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG
    Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired donor-specific hyporesponsiveness in long-term kidney allograft recipients.
    Reinsmoen NL; Matas A; Kaufman D; Sutherland D; Najarian JS; Bach FH
    Transplant Proc; 1991 Feb; 23(1 Pt 1):141-2. PubMed ID: 1824968
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of anti-idiotypic antibodies to HLA antigens in human hepatic allograft tolerance.
    Mohanakumar T; Hoover SK; Rhodes C; Mendez-Picon G; Flye MW; Lee HM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2437-9. PubMed ID: 3079084
    [No Abstract]   [Full Text] [Related]  

  • 31. HLA-DR1 recipients have the highest kidney transplant survival.
    Cook DJ; Cecka JM; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
    [No Abstract]   [Full Text] [Related]  

  • 32. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X; Ishida H; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
    Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
    Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA compatibility and liver transplant outcome: improved patient survival by HLA and crossmatching.
    Nikaein A; Backman L; Jennings L; Levy M; Goldstein R; Gonwa T; Stone M; Klintmalm G
    Transplant Proc; 1995 Feb; 27(1):1186-8. PubMed ID: 7878842
    [No Abstract]   [Full Text] [Related]  

  • 36. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethnic differences in HLA antigens in Chilean donors and recipients: data from the National Renal Transplantation Program.
    Droguett MA; Beltran R; Ardiles R; Raddatz N; Labraña C; Arenas A; Flores J; Alruiz P; Mezzano S; Ardiles L
    Transplant Proc; 2008 Nov; 40(9):3247-50. PubMed ID: 19010245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-donor DR103 Immunization in a DRB1*0101 kidney allograft recipient.
    Hajji K; Guignier F; Tanter Y; Rifle G; Mousson C
    Transplant Proc; 2006 Sep; 38(7):2306-7. PubMed ID: 16980073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.